BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35947285)

  • 1. Small Cell and Other Rare Histologic Types of Cervical Cancer.
    Marchocki Z; Swift B; Covens A
    Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases.
    Li JD; Zhuang Y; Li YF; Feng YL; Hou JH; Chen L; Zhu AN; Wu QL; Yun JP
    J Clin Pathol; 2011 Dec; 64(12):1102-7. PubMed ID: 21965825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
    Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M
    J Pathol; 2024 May; ():. PubMed ID: 38721894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.
    Satoh T; Takei Y; Treilleux I; Devouassoux-Shisheboran M; Ledermann J; Viswanathan AN; Mahner S; Provencher DM; Mileshkin L; Ă…vall-Lundqvist E; Pautier P; Reed NS; Fujiwara K
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S102-8. PubMed ID: 25341572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and Molecular Characteristics of Ovarian Carcinosarcoma.
    Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
    Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
    Kusakabe M; Taguchi A; Tanikawa M; Hoshi D; Tsuchimochi S; Qian X; Toyohara Y; Kawata A; Wagatsuma R; Yamaguchi K; Yamamoto Y; Ikemura M; Sone K; Mori-Uchino M; Matsunaga H; Tsuruga T; Nagamatsu T; Kukimoto I; Wada-Hiraike O; Kawazu M; Ushiku T; Takeyama H; Oda K; Kawana K; Hippo Y; Osuga Y
    Cancer Med; 2023 Apr; 12(7):8476-8489. PubMed ID: 36691316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome in small cell carcinoma of the cervix--a case series.
    Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
    Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
    Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
    J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
    BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
    Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
    Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
    Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
    PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
    Zhang Q; Xiong Y; Ye J; Zhang L; Li L
    PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
    Frumovitz M; Burzawa JK; Byers LA; Lyons YA; Ramalingam P; Coleman RL; Brown J
    Gynecol Oncol; 2016 Jun; 141(3):588-591. PubMed ID: 27079212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
    Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
    Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors.
    Kotsopoulos IC; Kucukmetin A; Mukhopadhyay A; Lunec J; Curtin NJ
    Int J Gynecol Cancer; 2016 May; 26(4):763-9. PubMed ID: 26905326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cervical cancer: Is there a role for poly (ADP-ribose) polymerase inhibition?
    Tomao F; Santangelo G; Musacchio L; Di Donato V; Fischetti M; Giancotti A; Perniola G; Petrella MC; Monti M; Palaia I; Muzii L; Benedetti Panici P
    J Cell Physiol; 2020 Jun; 235(6):5050-5058. PubMed ID: 31912897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.